de Haan L - Search Results

1

Patterns of obsessive-compulsive symptoms and social functioning in schizophrenia; a replication study.

Swets M, van Dijk FA, Schirmbeck F, Peen J, de Haan L, Alizadeh BZ, van Amelsvoort T, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, Delespaul P, Luykx JJ, Myin-Germeys I, Kahn RS, Simons CJP, van Haren NE, van Os J, van Winkel R. Swets M, et al. Among authors: de haan l. Psychiatry Res. 2019 Jan;271:421-427. doi: 10.1016/j.psychres.2018.11.071. Epub 2018 Dec 3. Psychiatry Res. 2019. PMID: 30537664

2

Comparable dopamine 2 receptor occupancy.

de Haan L, van Amelsvoort T. de Haan L, et al. Am J Psychiatry. 2002 Dec;159(12):2118; author reply 2118-9. doi: 10.1176/appi.ajp.159.12.2118. Am J Psychiatry. 2002. PMID: 12450982 No abstract available.

3

Olanzapine vs haloperidol for treatment of schizophrenia.

de Haan L, van Beveren N. de Haan L, et al. JAMA. 2004 Mar 3;291(9):1065; author reply 1065-6. doi: 10.1001/jama.291.9.1065-c. JAMA. 2004. PMID: 14996769 No abstract available.

4

Olanzapine and haloperidol for residual symptoms.

de Haan L, van Beveren N. de Haan L, et al. Am J Psychiatry. 2005 Jul;162(7):1392-3; author reply 1393. doi: 10.1176/appi.ajp.162.7.1392. Am J Psychiatry. 2005. PMID: 15994737 No abstract available.

5

Schizophrenia-associated neural growth factors in peripheral blood. A review.

van Beveren NJ, van der Spelt JJ, de Haan L, Fekkes D. van Beveren NJ, et al. Among authors: de haan l. Eur Neuropsychopharmacol. 2006 Oct;16(7):469-80. doi: 10.1016/j.euroneuro.2006.02.001. Epub 2006 Mar 20. Eur Neuropsychopharmacol. 2006. PMID: 16545550 Review.

6

Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis.

van Nimwegen L, de Haan L, van Beveren N, Laan W, van den Brink W, Linszen D. van Nimwegen L, et al. Among authors: de haan l. J Clin Psychopharmacol. 2008 Apr;28(2):214-8. doi: 10.1097/JCP.0b013e318166f520. J Clin Psychopharmacol. 2008. PMID: 18344733 Clinical Trial.

7

The revised dopamine hypothesis of schizophrenia: evidence from pharmacological MRI studies with atypical antipsychotic medication.

da Silva Alves F, Figee M, van Amelsvoort T, Veltman D, de Haan L. da Silva Alves F, et al. Among authors: de haan l. Psychopharmacol Bull. 2008;41(1):121-32. Psychopharmacol Bull. 2008. PMID: 18362875 Review.

8

Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial.

van Nimwegen LJ, de Haan L, van Beveren NJ, van der Helm M, van den Brink W, Linszen D. van Nimwegen LJ, et al. Among authors: de haan l. Can J Psychiatry. 2008 Jun;53(6):400-5. doi: 10.1177/070674370805300610. Can J Psychiatry. 2008. PMID: 18616861 Clinical Trial.

9

A visual metaphor describing neural dynamics in schizophrenia.

van Beveren NJ, de Haan L. van Beveren NJ, et al. Among authors: de haan l. PLoS One. 2008 Jul 9;3(7):e2577. doi: 10.1371/journal.pone.0002577. PLoS One. 2008. PMID: 18648540 Free PMC article.

10

White matter fibertracking in first-episode schizophrenia, schizoaffective patients and subjects at ultra-high risk of psychosis.

Peters BD, de Haan L, Dekker N, Blaas J, Becker HE, Dingemans PM, Akkerman EM, Majoie CB, van Amelsvoort T, den Heeten GJ, Linszen DH. Peters BD, et al. Among authors: de haan l. Neuropsychobiology. 2008;58(1):19-28. doi: 10.1159/000154476. Epub 2008 Sep 10. Neuropsychobiology. 2008. PMID: 18781087

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

933 results

Search Page

Filters